A single-centre, open-label, phase I trial evaluating the pharmacokinetics of single ascending oral doses of IRL757 in healthy elderly volunteers

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-515124-36-00

Acronym

IRL757C002

Enrollment

Registered

2024-09-09

Start date

2024-09-24

Completion date

2024-11-11

Last updated

2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apathy in neurodegenerative disorders

None listed

Sex/Gender

All

Age

65 Years to No maximum

Sweden

None listed

Source: EU CTIS · Data processed: Feb 4, 2026